Neurones (France) Today
NRO Stock | EUR 47.10 0.20 0.43% |
Performance8 of 100
| Odds Of DistressLess than 9
|
Neurones is trading at 47.10 as of the 17th of April 2024, a 0.43 percent up since the beginning of the trading day. The stock's open price was 46.9. Neurones has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Neurones are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of October 2023 and ending today, the 17th of April 2024. Click here to learn more.
Neurones S.A., an information technology services company, provides infrastructure, application, and consulting services in France and internationally. Neurones S.A. was founded in 1985 and is headquartered in Nanterre, France. NEURONES operates under Information Technology Services classification in France and is traded on Paris Stock Exchange. The company has 24.22 M outstanding shares. More on Neurones
Moving together with Neurones Stock
0.66 | CBDG | Compagnie du Cambodge | PairCorr |
Moving against Neurones Stock
0.51 | ALAGP | Agripower France | PairCorr |
0.48 | ALALO | Acheter Louer | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Neurones Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Neurones' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Neurones or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman | Luc Chammard |
Business Concentration | Information Technology, IT Services, Information Technology Services, Technology (View all Sectors) |
Neurones (NRO) is traded on Euronext Paris in France and employs 5,961 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Neurones's market, we take the total number of its shares issued and multiply it by Neurones's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Neurones operates under IT Services sector and is part of Information Technology industry. The entity has 24.22 M outstanding shares.
Neurones has accumulated about 169.6 M in cash with 64.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.2.
Check Neurones Probability Of Bankruptcy
Ownership AllocationNeurones holds a total of 24.22 Million outstanding shares. Neurones secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.71 % of Neurones outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Neurones Ownership Details
Neurones Stock Price Odds Analysis
What are Neurones' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Neurones jumping above the current price in 90 days from now is about 1.87%. The Neurones probability density function shows the probability of Neurones stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Neurones has a beta of -0.0663. This indicates as returns on the benchmark increase, returns on holding Neurones are expected to decrease at a much lower rate. During a bear market, however, Neurones is likely to outperform the market. Additionally, neurones has an alpha of 0.1207, implying that it can generate a 0.12 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Neurones to move above the current price in 90 days from now is about 1.87 (This Neurones probability density function shows the probability of Neurones Stock to fall within a particular range of prices over 90 days) .
Neurones Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Neurones market risk premium is the additional return an investor will receive from holding Neurones long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Neurones. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Neurones' alpha and beta are two of the key measurements used to evaluate Neurones' performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 0.8903 | |||
Semi Deviation | 1.0 | |||
Standard Deviation | 1.19 | |||
Variance | 1.43 |
Neurones Stock Against Markets
Picking the right benchmark for Neurones stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Neurones stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Neurones is critical whether you are bullish or bearish towards Neurones at a given time. Please also check how Neurones' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Neurones without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
All Next | Launch Module |
Neurones Corporate Directors
Neurones corporate directors refer to members of a Neurones board of directors. The board of directors generally takes responsibility for the Neurones' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Neurones' board members must vote for the resolution. The Neurones board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Daphne Chammard | Director - Representative of Host Developpement | Profile | |
Herve Pichard | Director | Profile | |
MarieFrancoise Jaubert | Director | Profile | |
Paul Bonnel | Director of Finance and Administration, IR Contact Officer | Profile |
How to buy Neurones Stock?
Before investing in Neurones, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Neurones. To buy Neurones stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Neurones. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Neurones stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Neurones stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Neurones stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Neurones, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Neurones?
The danger of trading Neurones is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Neurones is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Neurones. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Neurones is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurones. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stocks Directory Find actively traded stocks across global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |